Longboard Pharmaceuticals shares see spike as FDA recognizes potential of bexicaserin in Dravet syndrome

Longboard Pharmaceuticals shares see spike as FDA recognizes potential of bexicaserin in Dravet syndrome

Shares of Longboard Pharmaceuticals, Inc. surged on Thursday after the United States Food and Drug Administration (FDA) granted both Rare Pediatric Disease designation and Orphan Drug designation to its investigational drug, bexicaserin, for the treatment of Dravet syndrome. Pre-market trading saw shares rise by 4.2%, reaching $30.53, a continuation of the company’s upward trend over […]

New drug launch sends Lupin shares soaring to record highs! Find out what’s next

New drug launch sends Lupin shares soaring to record highs! Find out what’s next

Lupin Limited, a global pharmaceutical major, has seen its share price reach a 52-week high following the launch of its generic Mirabegron Extended-Release Tablets, 50 mg, in the United States. The approval from the United States Food and Drug Administration (USFDA) has enabled Lupin to introduce a generic equivalent of Myrbetriq Extended-Release Tablets, developed by […]